Estonian healthtech startup Antegenes secures €2.3 million to advance personalised cancer prevention

Published on August 2, 2022

Healthtech startup Antegenes are pioneering a personalised approach to cancer prevention. The innovative company has now raised a total of €2.3 million and is ready to bring its tests to new markets across Europe. Cancer is one of the most prevalent and deadly diseases facing society. It’s reported that 1 in 2 people will develop…

This content is for members only. Visit the site and log in/register to read.

The post Estonian healthtech startup Antegenes secures €2.3 million to advance personalised cancer prevention appeared first on EU-Startups.

Continue reading on website
Other news

Stockholm-based Bemlo bags over €3.2 million to tackle the European healthcare labour shortage

August 2, 2022
Getting a capital injection of over €3.2 million, Swedish startup Bemlo is aiming to tackle the growing labour shortage in Europe’s healthcare systems. The company is now aiming to expand into new markets.  Across Europe, healthcare systems are under immense pressure. A combination of having to manage a global pandemic, funding gaps and inefficient processes… This content is for members only. Visi

'Productivity Isn't The Problem — Lack of Creativity Is': Here Are 3 Ways To Foster A Creative Culture At Work.

August 2, 2022
We don't get to stretch our creative muscles like we used to. Here are three ways to bring it roaring back.